Total Payments
$142,166
2024 Payments
$25,898
Companies
45
Transactions
526
Medicare Patients
4,310
Medicare Billing
$1.0M
Payment Breakdown by Category
Other$102,960 (72.4%)
Travel$13,779 (9.7%)
Consulting$13,042 (9.2%)
Food & Beverage$12,212 (8.6%)
Education$172.54 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $88,260 | 41 | 62.1% |
| Honoraria | $14,700 | 6 | 10.3% |
| Travel and Lodging | $13,779 | 53 | 9.7% |
| Consulting Fee | $13,042 | 5 | 9.2% |
| Food and Beverage | $12,212 | 415 | 8.6% |
| Education | $172.54 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $107,471 | 206 | $0 (2024) |
| Avadel CNS Pharmaceuticals, LLC | $15,080 | 19 | $0 (2024) |
| Axsome Therapeutics, Inc. | $9,771 | 23 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $1,992 | 21 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $1,865 | 3 | $0 (2017) |
| Inspire Medical Systems, Inc. | $1,380 | 66 | $0 (2024) |
| Medtronic, Inc. | $962.29 | 13 | $0 (2024) |
| ABBVIE INC. | $353.51 | 24 | $0 (2024) |
| Eisai Inc. | $322.36 | 10 | $0 (2024) |
| Genentech USA, Inc. | $293.56 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25,898 | 167 | JAZZ PHARMACEUTICALS INC. ($12,126) |
| 2023 | $24,470 | 132 | Axsome Therapeutics, Inc. ($9,632) |
| 2022 | $13,721 | 67 | JAZZ PHARMACEUTICALS INC. ($13,061) |
| 2021 | $23,122 | 57 | JAZZ PHARMACEUTICALS INC. ($22,939) |
| 2020 | $7,099 | 17 | Jazz Pharmaceuticals Inc. ($7,071) |
| 2019 | $20,561 | 32 | Jazz Pharmaceuticals Inc. ($20,519) |
| 2018 | $17,895 | 33 | Jazz Pharmaceuticals Inc. ($17,810) |
| 2017 | $9,400 | 21 | Jazz Pharmaceuticals Inc. ($7,465) |
All Payment Transactions
526 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: NEUROLOGY | ||||||
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: PAIN | ||||||
| 12/16/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,450.00 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $121.86 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $34.20 | General |
| Category: Immunology | ||||||
| 12/11/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $31.29 | General |
| Category: Immunology | ||||||
| 12/10/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $32.30 | General |
| 12/09/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $33.15 | General |
| Category: NEUROLOGY | ||||||
| 12/06/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: NEUROLOGY | ||||||
| 12/06/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Immunology and Neurology | ||||||
| 12/05/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $33.70 | General |
| Category: Neurology | ||||||
| 12/03/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $32.96 | General |
| Category: Neurology | ||||||
| 12/02/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Neuropsychiatry | ||||||
| 11/27/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: NEUROLOGY | ||||||
| 11/22/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: NEUROLOGY | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: PAIN | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Neurology | ||||||
| 11/16/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: NEUROLOGY | ||||||
| 11/11/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $4.01 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/06/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $29.53 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/06/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 11/05/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $150.13 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/05/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/31/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Honoraria | Cash or cash equivalent | $2,800.00 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,303 | 2,257 | $1.7M | $346,283 |
| 2022 | 13 | 930 | 1,808 | $1.1M | $230,969 |
| 2021 | 11 | 948 | 1,839 | $582,535 | $179,892 |
| 2020 | 14 | 1,129 | 2,145 | $1.1M | $265,481 |
Total Patients
4,310
Total Services
8,049
Medicare Billing
$1.0M
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95715 | Measurement of brain wave activity with video (veeg), 12-26 hours with intermittent monitoring | Office | 2023 | 47 | 134 | $871,000 | $108,467 | 12.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 442 | 692 | $207,870 | $64,510 | 31.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 151 | 175 | $131,250 | $61,786 | 47.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 124 | 687 | $137,400 | $43,844 | 31.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 150 | 150 | $65,250 | $17,816 | 27.3% |
| 95724 | Measurement of brain wave activity with video (veeg), 61-84 hours with review and report by health care professional | Office | 2023 | 41 | 41 | $45,100 | $10,537 | 23.4% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2023 | 48 | 48 | $168,000 | $9,751 | 5.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 66 | 78 | $29,640 | $8,206 | 27.7% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 69 | 70 | $25,550 | $6,861 | 26.9% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 63 | 64 | $22,400 | $5,858 | 26.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 39 | $21,450 | $5,463 | 25.5% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 22 | 22 | $8,800 | $1,441 | 16.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 16 | 17 | $2,720 | $762.96 | 28.1% |
| 95977 | Electronic analysis of implanted neurostimulator generator with complex cranial nerve stimulator programming | Office | 2023 | 12 | 14 | $2,310 | $597.24 | 25.9% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Office | 2023 | 17 | 26 | $3,120 | $383.25 | 12.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 370 | 639 | $188,280 | $60,188 | 32.0% |
| 95715 | Measurement of brain wave activity with video (veeg), 12-26 hours with intermittent monitoring | Office | 2022 | 23 | 69 | $430,500 | $56,835 | 13.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 131 | 652 | $129,100 | $37,678 | 29.2% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 67 | 86 | $68,840 | $31,941 | 46.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 82 | 92 | $34,775 | $10,152 | 29.2% |
| 95724 | Measurement of brain wave activity with video (veeg), 61-84 hours with review and report by health care professional | Office | 2022 | 25 | 25 | $27,500 | $6,670 | 24.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 51 | 51 | $22,185 | $6,275 | 28.3% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2022 | 25 | 25 | $87,500 | $5,146 | 5.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 29 | 29 | $15,890 | $4,695 | 29.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 43 | 45 | $16,425 | $4,390 | 26.7% |
About Dr. Adrian Santamaria, MD
Dr. Adrian Santamaria, MD is a Sleep Medicine healthcare provider based in Tomball, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346444932.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adrian Santamaria, MD has received a total of $142,166 in payments from pharmaceutical and medical device companies, with $25,898 received in 2024. These payments were reported across 526 transactions from 45 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($88,260).
As a Medicare-enrolled provider, Santamaria has provided services to 4,310 Medicare beneficiaries, totaling 8,049 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Sleep Medicine
- Other Specialties Neurology
- Location Tomball, TX
- Active Since 06/14/2007
- Last Updated 03/30/2022
- Taxonomy Code 2084S0012X
- Entity Type Individual
- NPI Number 1346444932
Products in Payments
- XYWAV (Drug) $37,960
- Xyrem (Drug) $25,275
- XYREM (Drug) $22,583
- SUNOSI (Drug) $19,010
- LUMRYZ (Drug) $15,080
- Sunosi (Drug) $9,771
- BELSOMRA (Drug) $1,865
- WAKIX (Drug) $1,839
- INSPIRE (Device) $1,380
- PERCEPT PC BRAINSENSE (Device) $715.98
- Leqembi (Drug) $322.36
- ACTIVA PC (Device) $246.31
- UPLIZNA (Biological) $235.79
- KESIMPTA (Drug) $216.57
- NURTEC ODT (Drug) $195.05
- Wakix (Drug) $152.13
- UBRELVY (Drug) $151.41
- Ocrevus (Biological) $150.70
- OCREVUS (Biological) $142.86
- RYTARY (Drug) $137.55
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.